ALPN

Alpine Immune Sciences, Inc. Common Stock
ALPN

Overview Fund Activity
Delisted

ALPN was delisted on the 17th of May, 2024.

Back to rankings

76 hedge funds and large institutions have $380M invested in Alpine Immune Sciences, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 12 reducing their positions, and 2 closing their positions.

Holders
76
Holders Change
+16
Holders Change %
+26.67%
% of All Funds
1.2%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
18
Increased
34
Reduced
12
Closed
2
Calls
$52K
Puts
–
Net Calls
+$52K
Net Calls Change
+$52K

Top Buyers

1
VC
1
Vivo Capital
California
$9.41M
2
BlackRock
2
BlackRock
New York
$23.5M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$6.95M
4
TLP
4
Tri Locum Partners
New York
$3.41M
5
WP
5
Woodline Partners
California
$2.44M

Top Sellers

1
BI
1
BVF Inc
California
$0
2
LCM
2
Lynx1 Capital Management
Puerto Rico
$27.5M
3
OCA
3
Octagon Capital Advisors
New York
$7.71M
4
GPP
4
Great Point Partners
Connecticut
$34.6M
5
AAA
5
Affinity Asset Advisors
New York
$1.22M
Name Market Value Shares Shares
Change 		Shares
Change %
Nisa Investment Advisors
76
Nisa Investment Advisors
Missouri
$123 12 – –
BI
77
BVF Inc
California
– – -858,339 Closed
SG Americas Securities
78
SG Americas Securities
New York
– – -11,927 Closed
Simplex Trading
79
Simplex Trading
Illinois
– – – –
CFGS
80
Concourse Financial Group Securities
Alabama
– – – –
1 2 3
4